Sylvester Stallone-starrer ‘Samaritan’ on two-week hiatus over coronavirus outbreak
PTI, Mar 16, 2020, 9:52 AM IST
Los Angeles: Superhero film “Samaritan”, featuring Sylvester Stallone, is halting production for at least two weeks in the face of the coronavirus pandemic.
According to Deadline, MGM Studios announced that the cast and crew will be going on a break from Monday. The production was underway in Atlanta, Georgia.
“Samaritan” follows a young boy, played by “Euphoria” actor Javon Walton, who sets out to discover if a mythic superhero, who vanished 20 years earlier following a tragic event, remains alive.
Stallone will essay the role of Stanley Kominski, a sanitation worker trying to live a normal life while harboring a deep secret.
Natacha Karam will portray a dangerous and unpredictable henchperson to the story’s antagonist, played by “Game of Thrones” actor Pilou Asbake.
The film, set for a December 1 release, also features Martin Starr.
Last week, the World Health Organisation (WHO) declared the COVID-19 outbreak as a pandemic.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Actor Shiva Rajkumar to undergo surgery in the US next month
AR Rahman sends notice to ‘slanderers’ over speculations surrounding separation with Saira Banu
Awards don’t create value for independent films in India: Manoj Bajpayee
Aryan Khan to debut as director with Netflix series in 2025, SRK welcomes son to showbiz
AR Rahman, wife Saira Banu separating after 29 years of marriage: lawyer
MUST WATCH
Latest Additions
2020 Delhi riots: Court orders framing of charges against 25 accused in head constable death case
7 more arrested in Manipur for arson at legislators’ residences
2020 Delhi riots: Court orders framing of charges against 25 accused in head constable death case
Centre meeting floor leaders of political parties on Sunday ahead of Parliament Session
Charmadi Ghat highway set for widening: Work likely to begin in January 2025
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.